141 results
Page 4 of 8
424B3
p357h9g
17 Apr 14
Prospectus supplement
12:00am
8-K
EX-99.1
pc4jknut
27 Feb 14
Alimera Sciences Reports Fourth Quarter and Full Year 2013 Financial Results
12:00am
8-K
EX-99.1
7ac5uvhe
18 Dec 13
Agree Advisory Committee No Longer Necessary
12:00am
8-K
EX-99.1
h3h3w4peqdygzt5 w0
18 Oct 13
Alimera Continues Focus on European Growth
12:00am
8-K
EX-99.1
zrp22bm3 k0uwc8
14 Jun 13
Alimera Sciences Announces Issuance of a Positive Appraisal Recommendation on IluvienĀ® for Consultation In the United Kingdom
12:00am
424B3
0n5iwvmgfwy7pfr
8 May 13
Prospectus supplement
12:00am
8-K
EX-99.1
y2xowemqprzog2khmkz
7 May 13
Other Events
12:00am
8-K
EX-99.1
r9qi0lc1wzoaxnsv53
1 May 13
Other Events
12:00am
8-K
EX-99.1
0ma15zk488c8vcx
29 Apr 13
Simple Patient Access Scheme has been submitted to NICE for rapid review
12:00am
8-K
EX-99.1
jhglhg38ofu mt5rt19x
21 Mar 13
Alimera Sciences Reports Fourth Quarter 2012 Financial Results
12:00am